CHMP Endorses SPEVIGO® – Expanding Horizons in Dermatology
SPEVIGO® is currently approved in 51 countries for the treatment of GPP flares, and the CHMP opinion follows similar approvals for expanded and new indications […]
SPEVIGO® is currently approved in 51 countries for the treatment of GPP flares, and the CHMP opinion follows similar approvals for expanded and new indications […]
Copyright © 2024 | WordPress Theme by MH Themes